Antibiotic Treatment for Uncomplicated Abdominal Wall Cellulitis
For uncomplicated cellulitis of the abdominal wall without abscess, treat with a β-lactam antibiotic such as cephalexin (500 mg four times daily) or penicillin for 5 days if clinical improvement occurs by that time. 1
Recommended Antibiotic Regimen
The IDSA guidelines establish that β-lactam monotherapy is the appropriate treatment for non-purulent cellulitis 1. Specifically:
- First-line options: Cephalexin, penicillin, or amoxicillin
- Duration: 5 days is as effective as 10 days when clinical improvement is evident 1
- MRSA coverage is NOT needed for typical cellulitis without purulent drainage 1, 2
This recommendation is strongly supported by a high-quality randomized controlled trial published in JAMA (2017) that demonstrated cephalexin plus trimethoprim-sulfamethoxazole was no more effective than cephalexin alone for uncomplicated cellulitis, with clinical cure rates of 83.5% vs 85.5% respectively 2. This definitively shows that adding MRSA coverage provides no benefit.
Why β-Lactam Monotherapy Works
The causative organisms in non-purulent cellulitis are predominantly:
- β-hemolytic streptococci (most common)
- Methicillin-sensitive Staphylococcus aureus
MRSA is an unusual cause of typical cellulitis 1. A prospective study showed that β-lactams like cefazolin or oxacillin were successful in 96% of cellulitis cases, confirming MRSA coverage is usually unnecessary 1.
When to Consider MRSA Coverage
Add MRSA-active antibiotics (vancomycin, daptomycin, linezolid, or oral doxycycline/clindamycin/TMP-SMX) ONLY if:
- Penetrating trauma present
- Illicit drug use involved
- Purulent drainage exists
- Concurrent MRSA infection elsewhere 1
None of these apply to simple abdominal wall cellulitis without abscess, so stick with β-lactam monotherapy.
Treatment Duration
- 5 days is sufficient if clinical improvement occurs 1
- Extend only if symptoms have not improved by day 5
- Average hospitalized patients receive 2 weeks, but this is often excessive for uncomplicated cases 1
Common Pitfalls to Avoid
Do not use broad-spectrum antibiotics unnecessarily: Two-thirds of hospitalized cellulitis patients receive overly broad coverage with no improvement in outcomes (12% failure rate regardless of spectrum) 1
Do not add TMP-SMX or doxycycline: Their activity against β-hemolytic streptococci is unknown, and the JAMA trial proved no benefit 1, 2
Expect initial worsening: Some patients experience increased inflammation after starting antibiotics due to pathogen destruction releasing inflammatory enzymes—this does not indicate treatment failure 1
Confirm it's actually cellulitis: Bilateral cellulitis is rare; consider venous stasis dermatitis, contact dermatitis, or other mimickers 3, 4